Terms: = Uterine cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Treatment
11 results:
1. Systematic assessment of tumor necrosis at baseline in cervical cancer - An independent factor associated with poor outcome.
Chouchane-Mlik O; Oniga A; Latouche A; Halladjian M; Kleine-Borgmann FB; Gérardy JJ; Mittelbronn M; Kamal M; Scholl SM
Hum Pathol; 2024 Jan; 143():62-70. PubMed ID: 38135059
[TBL] [Abstract] [Full Text] [Related]
2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
3. Cellular and extracellular vaginal changes following murine ovarian removal.
McCracken JM; Calderon GA; Le QN; Faruqui NM; Balaji S; Hakim JCE
Physiol Rep; 2023 Aug; 11(15):e15762. PubMed ID: 37549960
[TBL] [Abstract] [Full Text] [Related]
4. Characterization and Clinical Relevance of Endometrial CAFs: Correlation between Post-Surgery Event and Resistance to Drugs.
Sulaiman R; De P; Aske JC; Lin X; Dale A; Gaster K; Espaillat LR; Starks D; Dey N
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047422
[TBL] [Abstract] [Full Text] [Related]
5. Circulating Tumor Cells In Advanced Cervical cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062).
Tewari KS; Sill MW; Monk BJ; Penson RT; Moore DH; Lankes HA; Ramondetta LM; Landrum LM; Randall LM; Oaknin A; Leitao MM; Eisenhauer EL; DiSilvestro P; Van Le L; Pearl ML; Burke JJ; Salani R; Richardson DL; Michael HE; Kindelberger DW; Birrer MJ
Mol Cancer Ther; 2020 Nov; 19(11):2363-2370. PubMed ID: 32847980
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical and Pathologic Features of Myeloid Sarcoma].
Jiang YJ; Wang HX; Zhuang WC; Chen H; Zhang C; Li XM; Zhu GH; He Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):926-931. PubMed ID: 28641661
[TBL] [Abstract] [Full Text] [Related]
7. Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.
Ricci F; Fratelli M; Guffanti F; Porcu L; Spriano F; Dell'Anna T; Fruscio R; Damia G
Oncotarget; 2017 Jan; 8(5):7441-7451. PubMed ID: 26910918
[TBL] [Abstract] [Full Text] [Related]
8. Stro-1/CD44 as putative human myometrial and fibroid stem cell markers.
Mas A; Nair S; Laknaur A; Simón C; Diamond MP; Al-Hendy A
Fertil Steril; 2015 Jul; 104(1):225-34.e3. PubMed ID: 25989979
[TBL] [Abstract] [Full Text] [Related]
9. [Study on the clinicopathologic features of 88 cases with mucinous cervical adenocarcinoma].
Zeng SY; Zhong ML; Liang MR; Li L; Jiang W; Yu XH
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):602-6. PubMed ID: 24199926
[TBL] [Abstract] [Full Text] [Related]
10. Prediction of clinical toxicity in localized cervical carcinoma by radio-induced apoptosis study in peripheral blood lymphocytes (PBLs).
Bordón E; Henríquez Hernández LA; Lara PC; Pinar B; Fontes F; Rodríguez Gallego C; Lloret M
Radiat Oncol; 2009 Nov; 4():58. PubMed ID: 19941649
[TBL] [Abstract] [Full Text] [Related]
11. The loss of lectin reactivity from human endometrium is a feature of malignant change.
Sivridis E; Agnantis N
Pathol Res Pract; 1996 Oct; 192(10):989-97. PubMed ID: 8958548
[TBL] [Abstract] [Full Text] [Related]
